“Prior to allocating additional resources for expansion of our product portfolio, Strategy Inc. performed a worldwide market due diligence analysis to validate clinical need and market perceptions. The project entailed numerous decision makers and influencers in the complicated critical care environment. Strategy Inc. was able to drill down to the key issues that would enable us to make a decision based on the results of their work.

Their thorough analysis covering a range of stakeholders across the globe enabled our team to make strategic decisions with confidence by confirming several assumptions, quantifying market need and discovering key trends to ensure successful positioning of our technology.” Jiny Kim, Senior Product Manager Pressure Monitoring Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring selling medical technologies in nearly 100 countries with 2019 sales of $4.3 billion.